CAS: 158899-10-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TLN-232 REF: TM-T70418CAS: 158899-10-6 | - - - | 2,396.00 €~4,289.00 € | Tue 18 Mar 25 |
 | (4R,7S,10R,13R)-10-((1H-Indol-3-yl)methyl)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-13-((R)-2-amino-3-phenylpropanamido)-7-(4-a minobutyl)-6,9,12-trioxo-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxamide REF: 3D-IGA89910CAS: 158899-10-6 | Min. 95% | - - - | Discontinued product |
TLN-232
CAS:158899-10-6
TLN-232, a synthetic heptapeptide, may inhibit cancer by targeting M2PK to disrupt tumor cell energy …
Formula:
C36H49N9O7S2
Color and Shape:
Liquid
Molecular weight:
783.96
Ref: TM-T70418
| 25mg | 2,396.00 € | ||
| 50mg | 3,152.00 € | ||
| 100mg | 4,289.00 € |
Estimated delivery in United States, on Tuesday 18 Mar 2025
(4R,7S,10R,13R)-10-((1H-Indol-3-yl)methyl)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-13-((R)-2-amino-3-phenylpropanamido)-7-(4-a minobutyl)-6,9,12-trioxo-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxamide
CAS:158899-10-6
(4R,7S,10R,13R)-10-((1H-Indol-3-yl)methyl)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-13-(2-(2-(2-(2-(2-(2-(2-(2 -(pyridin--4 (1H) methoxy) phenyl) ethoxy) ethoxy) ethoxy) ethoxy) ethoxy) propanamido)-7-(4-[(dimethylamino)methyl]butyl)-6,9,12--trioxo--1,2--dithia--5,8,11--triazacyclotetrad eca ne -4 carboxamide …
Formula:
C36H49N9O7S2
Purity:
Min. 95%
Molecular weight:
784 g/mol
Ref: 3D-IGA89910
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
